Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Editor's Picks
8/20/2024
Taking Stock of U.S.-China Biotechnology Competition (Asia Society)
8/15/2024
Patent Term Compensation: New Policy Interpretation And Operation Guid...
8/14/2024
China Biopharma Tracker – July 2024 (PharmaDJ)
8/7/2024
How to Patent Targeted Therapy Pharmaceuticals in China (IAM)
8/6/2024
Buyout of China's Drug Companies by Global Pharma Giants Sparks Nation...
8/5/2024
Association of Lifestyle with Sleep Health In General Population in Ch...
8/5/2024
Chinese Innovative Drug R&D Trends in 2024: PharmaDJ
7/31/2024
AstraZeneca CEO Talks Dual Supply Chain Strategy (Yahoo Finance)
7/31/2024
Chinese Innovative Drug R&D Trends in 2024 (Nature)
7/26/2024
Congress targeting trials at Chinese Military Hospitals and in Xinjian...
7/24/2024
Breaking Barriers and Accelerating Growth: Clinical Trials, Drug Appro...
7/24/2024
Why (And How) to HIDE Your IP from an Increasingly Rapacious China (Mo...
7/19/2024
Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
7/16/2024
China's Health Supplements Market: Trends and Opportunities for Busine...
7/16/2024
Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
7/15/2024
China's Once-booming Online Healthcare Sector Sees Its Vital Signs Sin...
7/15/2024
Will US Clinical Study Diversity Guidance Cloud Chinese Firms' Prospec...
7/15/2024
China Biopharma Tracker – H1/2024 (PharmaNJ)
7/15/2024
China's Fast-following Approach Positions It at the Forefront of the F...
7/12/2024
Prominence of Asia in Global Pharma Clinical Trials Rising Substantial...
7/11/2024
Political Change Around China Means Change for Pharma (The Medicine Ma...
7/11/2024
Biopharma Partnership Interest with China Remains High: LEK Survey
7/10/2024
House Speaker Mike Johnson Pledges Vote for BIOSECURE as China-targeti...
7/9/2024
China's Pharmaceutical Industry Bets Big on Small Nucleic Acid Drugs i...
7/9/2024
China's Supreme People's Court Clarifies Priority Examination Standard...
7/2/2024
What is the Current Landscape of Obesity Drug Development in China? (L...
6/27/2024
Industry Braces for Biosecure Act Impact (C&EN)
6/26/2024
On Efficiency of China's Drug-Related Patent Term Compensation System ...
6/25/2024
Leveraging Injunctive Relief in Pharmaceutical Patent Disputes in Chin...
6/20/2024
Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
Page:
5
/
7
Total number of articles:
182
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit